Development and validation of a nomogram for predicting refractory peritoneal dialysis related peritonitis

References

• Mcgill RL, Weiner DE, Ruthazer R, et al. Transfers to hemodialysis among US patients initiating renal replacement therapy with peritoneal dialysis. Am J Kidney Dis. 2019;74(5):1–12. doi: 10.1053/j.ajkd.2019.05.014.
   PubMed Web of Science ®Google Scholar
• Trionfetti F, Marchant V, González-Mateo GT, et al. Novel aspects of the immune response involved in the peritoneal damage in chronic kidney disease patients under dialysis. Int J Mol Sci. 2023;24(6):24. doi: 10.3390/ijms24065763.
   Web of Science ®Google Scholar
• Zelenitsky SA, Howarth J, Lagacé-Wiens P, et al. Microbiological trends and antimicrobial resistance in peritoneal dialysis-related peritonitis, 2005 to 2014. Perit Dial Int. 2017;37(2):170–176. doi: 10.3747/pdi.2016.00136.
   PubMed Web of Science ®Google Scholar
• Thammishetti V, Kaul A, Bhadauria DS, et al. A retrospective analysis of etiology and outcomes of refractory CAPD peritonitis in a tertiary care center from North India. Perit Dial Int. 2018;38(6):441–446. doi: 10.3747/pdi.2017.00145.
   PubMed Web of Science ®Google Scholar
• Lee CC, Tu KH, Chen HH, et al. Risk factors for drainage-requiring ascites after refractory peritonitis in peritoneal dialysis patients. Int Urol Nephrol. 2016;48(10):1721–1730. doi: 10.1007/s11255-016-1376-y.
   PubMed Web of Science ®Google Scholar
• Liang Q, Zhao H, Wu B, et al. Effect of different dialysis duration on the prognosis of peritoneal dialysis-associated peritonitis: a single-center, retrospective study. Ren Fail. 2023;45(1):2177496. doi: 10.1080/0886022X.2023.2177496.
   PubMed Web of Science ®Google Scholar
• Liao CT, Zheng CM, Lin YC, et al. Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients. Sci Rep. 2021;11(1):1171. doi: 10.1038/s41598-020-80938-2.
   PubMed Web of Science ®Google Scholar
• Admas T, Banjaw A. Healthcare professionals’ knowledge, attitudes and future expectations towards personalized medicine. Per Med. 2021;18(5):483–490. doi: 10.2217/pme-2020-0185.
   PubMedGoogle Scholar
• Li PK, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42(2):110–153. doi: 10.1177/08968608221080586.
   PubMed Web of Science ®Google Scholar
• Shariat SF, Capitanio U, Jeldres C, et al. Can nomograms be superior to other prediction tools? BJU Int. 2009;103(4):492–497. doi: 10.1111/j.1464-410X.2008.08073.x.
   PubMed Web of Science ®Google Scholar
• Meng L, Zhu X, Yang L, et al. Development and vali­dation of a prediction model for treatment failure in peritoneal dialysis-associated peritonitis patients: a multicenter study. Nan Fang Yi Ke Da Xue Xue Bao. 2022;42(4):546–553. doi: 10.12122/j.issn.1673-4254.2022.04.10.
   PubMedGoogle Scholar
• Yao Z, Zhang Y, Wu H. Regulation of C-reactive protein conformation in inflammation. Inflamm. Res. 2019;68(10):815–823. doi: 10.1007/s00011-019-01269-1.
   PubMed Web of Science ®Google Scholar
• Mao Y, Xiao D, Deng S, et al. Development of a clinical risk score system for peritoneal dialysis-associated peritonitis treatment failure. BMC Nephrol. 2023;24(1):229. doi: 10.1186/s12882-023-03284-1.
   PubMed Web of Science ®Google Scholar
• Gremese E, Bruno D, Varriano V, et al. Serum albumin levels: a biomarker to be repurposed in different disease settings in clinical practice. J Clin Med. 2023;12(18):6017. doi: 10.3390/jcm12186017.
   Web of Science ®Google Scholar
• Dai R, Peng C, Sang T, et al. Construction and validation of a predictive model for the risk of peritoneal dialysis-associated peritonitis after peritoneal dialysis catheterization. Front Med. 2023;10:1193754. doi: 10.3389/fmed.2023.1193754.
   Web of Science ®Google Scholar
• Yu GQ, Chen J, Li JX. The association between peritoneal charge barrier dysfunction and protein lost during continuous ambulatory peritoneal dialysis. Kidney Blood Press Res. 2013;37(4–5):252–258. doi: 10.1159/000350150.
   PubMed Web of Science ®Google Scholar
• Yu Z, Lambie M, Chess J, et al. Peritoneal protein clearance is a function of local inflammation and membrane area whereas systemic inflammation and comorbidity predict survival of incident peritoneal dialysis patients. Front Physiol. 2019;10:105. doi: 10.3389/fphys.2019.00105.
   PubMed Web of Science ®Google Scholar
• Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–437. doi: 10.1111/j.0894-0959.2004.17603.x.
   PubMed Web of Science ®Google Scholar
• Liu X, Qin A, Zhou H, et al. Novel predictors and risk score of treatment failure in peritoneal dialysis-related peritonitis. Front Med. 2021;8:639744. doi: 10.3389/fmed.2021.639744.
   Web of Science ®Google Scholar
• Meng LF, Yang LM, Zhu XY, et al. Comparison of clinical features and outcomes in peritoneal dialysis-associated peritonitis patients with and without diabetes: a multicenter retrospective cohort study. World J Diabetes. 2020;11(10):435–446. doi: 10.4239/wjd.v11.i10.435.
   PubMed Web of Science ®Google Scholar
• Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41(3):281–288. doi: 10.1086/431587.
   PubMed Web of Science ®Google Scholar
• Santamaría B, Sanz A, Justo P, et al. Peritoneal defence–lessons learned which apply to diabetes complications. Nephrol Dial Transplant. 2006;21(Suppl 2):ii12–ii15. doi: 10.1093/ndt/gfl185.
   PubMedGoogle Scholar
• Ran Q, Zhao X, Tian J, et al. A nomogram model for predicting malnutrition among older hospitalized patients with type 2 diabetes: a cross-sectional study in China. BMC Geriatr. 2023;23(1):565. doi: 10.1186/s12877-023-04284-4.
   PubMed Web of Science ®Google Scholar
• Guo S, Yang L, Zhu X, et al. Multidrug-resistant organism-peritoneal dialysis associated peritonitis: clinical and microbiological features and risk factors of treatment failure. Front Med. 2023;10:1132695. doi: 10.3389/fmed.2023.1132695.
   Web of Science ®Google Scholar
• Bartosova M, Schaefer B, Vondrak K, et al. Peritoneal dialysis vintage and glucose exposure but not peritonitis episodes drive peritoneal membrane transformation during the first years of PD. Front Physiol. 2019;10:356. doi: 10.3389/fphys.2019.00356.
   PubMed Web of Science ®Google Scholar
• Parikova A, Hruba P, Krediet RT, et al. Long-term peritoneal dialysis treatment provokes activation of genes related to adaptive immunity. Physiol Res. 2019;68(5):775–783. doi: 10.33549/physiolres.934158.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Jiang L, Lu Y, et al. Peritoneal dialysis-related peritonitis caused by gram-negative organisms: ten-years experience in a single center. Ren Fail. 2021;43(1):993–1003. doi: 10.1080/0886022X.2021.1939050.
   PubMed Web of Science ®Google Scholar
• Lin WH, Tseng CC, Wu AB, et al. Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Escherichia coli in southern Taiwan. Eur J Clin Microbiol Infect Dis. 2018;37(9):1699–1707. doi: 10.1007/s10096-018-3302-y.
   PubMed Web of Science ®Google Scholar
• Dias RCB, Vieira MA, Moro AC, et al. Characterization of Escherichia coli obtained from patients undergoing peritoneal dialysis and diagnosed with peritonitis in a Brazilian centre. J Med Microbiol. 2019;68(9):1330–1340. doi: 10.1099/jmm.0.001043.
   PubMed Web of Science ®Google Scholar
• Ribera-Sánchez R, Pérez-Fontán M, López-Iglesias A, et al. Comprehensive approach to peritoneal dialysis-related peritonitis by enteric microorganisms. comparison between single organism and polymicrobial infections. Perit Dial Int. 2018;38(2):139–146. doi: 10.3747/pdi.2017.00184.
   PubMed Web of Science ®Google Scholar